Researchers at Rocky Mountain Laboratories in Hamilton, MT with collaborating scientists in Japan have developed a new assay for quantitating prions for neurodegenerative disease research. This new assay, Real-Time Quaking Induced Conversion Assay (RT-QuIC) is a faster, higher throughput, and more sensitive assay for prions than compared to previous test methods using biological tissue samples from infected animals.
This new prion assay can be measured using BMG LABTECH’s Omega series of microplate readers . With the Omega’s powerful control and MARS Data Analysis Software, researchers can easily perform this prion assay in several hours to a few days, compared to months with the previous technique in animals. For more information please see their publication: Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays in PLoS Pathogen (6(12): e1001217. doi:10.1371/journal.ppat.1001217).
See BMG LABTECH’s Rocky Mountain Laboratory customer focus for more information on this new prion disease assay.